Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294095 describes a non-coding RNA transcript found on the strand opposite to the protein-coding gene Nuclear respiratory factor 1 (NRF1). Such antisense transcripts sometimes play regulatory roles, potentially modulating the expression of their sense counterparts, but the biological function for this specific transcript is currently unknown and not experimentally characterized[1]. It is not a canonical therapeutic target such as a receptor, enzyme, or transporter, nor are there known drugs or mechanisms of action associated with it. This entry is likely a genomic annotation artifact and should not be treated as a standalone molecular drug target for structured databases. If you need information about the canonical NRF1 protein (a transcription factor relevant in cellular metabolism and mitochondrial biogenesis), its data would be different[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to Nuclear respiratory factor 1 (ENSG00000294095).